CVA Family Office’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $205K | Buy |
745
+14
| +2% | +$3.86K | 0.03% | 287 |
|
|
2025
Q1 | $194K | Sell |
731
-104
| -12% | -$27.6K | 0.03% | 280 |
|
|
2024
Q4 | $194K | Buy |
835
+399
| +92% | +$92.7K | 0.03% | 275 |
|
|
2024
Q3 | $96.2K | Buy |
436
+46
| +12% | +$10.2K | 0.02% | 380 |
|
|
2024
Q2 | $76.7K | Buy |
390
+3
| +0.8% | +$590 | 0.01% | 404 |
|
|
2024
Q1 | $83.3K | Sell |
387
-23
| -6% | -$4.95K | 0.01% | 394 |
|
|
2023
Q4 | $86.3K | Buy |
+410
| New | +$86.3K | 0.02% | 355 |
|
|
2023
Q3 | – | Sell |
-347
| Closed | -$64.3K | – | 368 |
|
|
2023
Q2 | $64.3K | Sell |
347
-66
| -16% | -$12.2K | 0.01% | 384 |
|
|
2023
Q1 | $79.1K | Buy |
413
+293
| +244% | +$56.1K | 0.02% | 345 |
|
|
2022
Q4 | $20.2K | Sell |
120
-205
| -63% | -$34.5K | ﹤0.01% | 562 |
|
|
2022
Q3 | $58K | Buy |
325
+55
| +20% | +$9.82K | 0.02% | 327 |
|
|
2022
Q2 | $55K | Sell |
270
-270
| -50% | -$55K | 0.02% | 348 |
|
|
2022
Q1 | $128K | Buy |
540
+185
| +52% | +$43.9K | 0.03% | 225 |
|
|
2021
Q4 | $81K | Buy |
355
+130
| +58% | +$29.7K | 0.02% | 277 |
|
|
2021
Q3 | $38K | Sell |
225
-228
| -50% | -$38.5K | 0.03% | 211 |
|
|
2021
Q2 | $96K | Buy |
453
+163
| +56% | +$34.5K | 0.03% | 247 |
|
|
2021
Q1 | $59K | Buy |
290
+265
| +1,060% | +$53.9K | 0.02% | 256 |
|
|
2020
Q4 | $5K | Sell |
25
-200
| -89% | -$40K | ﹤0.01% | 321 |
|
|
2020
Q3 | $38K | Buy |
+225
| New | +$38K | 0.03% | 211 |
|